According to a previous research, miR-760 develops a drug-resistant function via impairing doxorubicin resistance in hepatocellular carcinoma by controlling Notch1/Hes1-PTEN/Akt signaling pathway [23]. This evidence concerns the gene NOTCH1 and hepatocellular carcinoma.